BD FACSDiscover™ S8 Cell Sorter
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH), specifically the National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research, plans to award a sole source, firm-fixed-price contract to Becton, Dickinson and Company / BD Biosciences for the purchase of a BD FACSDiscover™ S8 Cell Sorter. This acquisition is intended to replace outdated cell sorting instruments and provide advanced features essential for ongoing and future intramural research. The instrument must support high-parameter cell sorting, spectral flow cytometry, integrated real-time imaging, and the ability to analyze and sort cells based on various parameters including fluorescence, morphology, and image-derived data. It also requires biosafety compliance for sorting human cells, as well as support for rare-cell, index, and plate sorting. The contract is announced as a notice of intent rather than a solicitation for competitive bids and will be awarded under statutory authority allowing sole source procurement because only one responsible source meets the agency's requirements. The project, with an anticipated delivery and installation timeline of 60 to 90 days post-award, includes a one-year warranty. The contract will be processed as an open-market acquisition with the place of performance in Bethesda, Maryland. Primary contacts for the contract are available via NIH, ensuring communication and coordination for delivery and acceptance.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Office of Logistics and Acquisition Operations (OLAO)
For:
National Institute of Dental and Craniofacial Research (NIDCR)
Division of Intramural Research (DIR)
Combined Technical Research Core (CTRC)
2. Action Being Announced
This is a notice of intent, and not a request for competitive quotations, proposals, or bids.
The National Institutes of Health (NIH), on behalf of the National Institute of Dental and Craniofacial Research (NIDCR), intends to negotiate and award a firm-fixed-price sole source contract to:
Becton, Dickinson and Company / BD Biosciences
for the acquisition of one (1) BD FACSDiscover™ S8 Cell Sorter, including required configuration, delivery, installation, biosafety-compliant hood, and standard warranty coverage.
Project Number: PCA-NIDCR-01222
Project Title: BD FACSDiscover™ S8 Cell Sorter
3. Statutory Authority
The Government intends to award this requirement on a sole source basis pursuant to:
- 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements; and
- as applicable to this acquisition, 41 U.S.C. 1901 and FAR 13.501(a)(1)(ii).
This requirement will be processed as an open-market acquisition.
4. Description of Requirement
The National Institute of Dental and Craniofacial Research (NIDCR), Division of Intramural Research (DIR), Combined Technical Research Core (CTRC), requires the acquisition of a highly specialized commercial laboratory instrument to replace aging and end-of-life cell sorting instruments and to provide advanced capabilities necessary to support current and future NIH intramural research.
The required instrument must provide, at a minimum, the following capabilities:
- Cell sorting capability for high-parameter research applications;
- Spectral flow cytometry capability;
- Integrated real-time imaging during acquisition and/or sorting;
- Ability to analyze and sort cells based on fluorescence/spectral signatures, morphology, and image-derived parameters;
- Support for rare-cell sorting;
- Support for index sorting and plate sorting; and
- A biosafety-compliant configuration suitable for sorting human cells in NIH research environments.
The anticipated delivery period is 60 to 90 days after award for delivery, installation, and acceptance. The acquisition includes a one-year warranty following installation and acceptance.
